Avalo Therapeutics (AVTX) FCF Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -735,100.00 |
| Sep 30, 2024 | -173,271.00 |
| Dec 31, 2023 | -5,528.00 |
| Sep 30, 2023 | -293,465.00 |
| Jun 30, 2023 | -50,219.00 |
| Mar 31, 2023 | -77,974.00 |
| Dec 31, 2022 | 738,366.00 |
| Sep 30, 2022 | 125,071.00 |
| Jun 30, 2022 | -64,069.00 |
| Mar 31, 2022 | 250,701.00 |
| Dec 31, 2021 | -685,253.00 |
| Sep 30, 2021 | -13,859.00 |
| Jun 30, 2021 | 6,749.00 |
| Mar 31, 2021 | -366,836.00 |
| Dec 31, 2020 | -67,093.00 |
| Sep 30, 2020 | -72,790.00 |
| Jun 30, 2020 | -15,027.00 |
| Mar 31, 2020 | -8,078.00 |
| Dec 31, 2019 | -32,852.00 |
| Sep 30, 2019 | -33,201.00 |
| Jun 30, 2019 | -48,201.00 |
| Mar 31, 2019 | -12,092.00 |
| Dec 31, 2018 | 17,339.00 |
| Sep 30, 2018 | -9,053.00 |
| Jun 30, 2018 | 110,762.00 |
| Mar 31, 2018 | 57,589.00 |
| Dec 31, 2017 | 191,097.00 |
| Sep 30, 2017 | 114,649.00 |
| Jun 30, 2017 | -54,133.00 |